Dianthus Therapeutics, Inc. · NASDAQ:DNTH

BCLS Fund III Investments, LP's stake in Dianthus Therapeutics, Inc. fell to 3.10% (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 14, 2025

BCLS Fund III Investments, LP's stake in Dianthus Therapeutics, Inc. fell to 3.10%, 1,315,892 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).

Stake
3.10%
Shares
1,315,892
Intent
Passive
What changed
Fell below 5%

The filing in full

HolderStakeShares
BCLS Fund III Investments, LP3.10%1,315,892

Source

View original at SEC

Related